GlaxoSmithKline reported 3.64B in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbvie ABBV:US $ 4021M 259M
Alcon AG ALC:SW 972M 29M
Amgen AMGN:US $ 1561M 157M
Artemis Alpha ATS:LN 632K 37K
AstraZeneca AZN:LN 2279M 790M
Bayer BAYN:GR € 5176M 1491M
Biogen BIIB:US $ 753.9M 93.8M
Bristol Myers Squibb BMY:US $ 2471M 115M
Eli Lilly And LLY:US $ 2072.1M 21.9M
Fresenius FRE:GR € 7162M 92M
Fresenius Medical Care FME:GR € 3290.27M 37.59M
Galapagos GLPG:NA 2.91M 1.94M
Gilead Sciences GILD:US $ 1424M 1203M
GlaxoSmithKline GSK:LN 3645M 30M
Glaxosmithkline GSK:US $ 3645M 30M
GRIFOLS GRF:SM € 771.1M 119.7M
H. Lundbeck A/S LUN:DC 845M 155M
Hikma Pharmaceutical HIK:LN 652M 52M
Lonza Group LONN:SW 1.8B 301M
Merck MRK:GR € 1987M 28M
Merk MRK:US $ 5334M 1507M
Novartis NOVN:VX SF 3755M 245M
Orion ORNBV:FH 106.1M 16.8M
Pfizer PFE:US $ 10010M 399M
Philips PHIA:NA € 2407M 618M
Recordati REC:IM 115.48M 756K
Regeneron Pharmaceuticals REGN:US $ 404.9M 577.7M